Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 0.37.

  • Fortress Biotech's Asset Utilization Ratio fell 2033.28% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 2033.28%. This contributed to the annual value of 0.37 for FY2024, which is 109.7% up from last year.
  • Fortress Biotech's Asset Utilization Ratio amounted to 0.37 in Q3 2025, which was down 2033.28% from 0.35 recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Asset Utilization Ratio registered a high of 0.53 during Q2 2024, and its lowest value of 0.12 during Q1 2021.
  • For the 5-year period, Fortress Biotech's Asset Utilization Ratio averaged around 0.32, with its median value being 0.28 (2023).
  • Per our database at Business Quant, Fortress Biotech's Asset Utilization Ratio tumbled by 3542.16% in 2021 and then surged by 12476.49% in 2024.
  • Quarter analysis of 5 years shows Fortress Biotech's Asset Utilization Ratio stood at 0.17 in 2021, then soared by 42.1% to 0.24 in 2022, then skyrocketed by 118.62% to 0.53 in 2023, then fell by 19.99% to 0.43 in 2024, then fell by 14.13% to 0.37 in 2025.
  • Its last three reported values are 0.37 in Q3 2025, 0.35 for Q2 2025, and 0.36 during Q1 2025.